Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

February 21, 2019

Peloton Therapeutics secures $150m in Series E financing

Peloton Therapeutics, Inc., a drug discovery and development company advancing first-in-class oral medicines for cancer and other serious conditions, today announced the closing of an oversubscribed $150 million Series E financing.

Peloton Therapeutics secures $150m in Series E financing